EW - Latest News
Edwards Lifesciences Corporation (EW), operates in Healthcare / Medical - Devices, trades on NYSE.
Market capitalization stands near $52.74B. Trailing twelve-month P/E ratio is 52.54. Beta to the broader market is 0.85.
The article list below shows the most recent EW headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent EW Headlines
Is EW Stock Worth Buying as Growth Clashes With a Premium Valuation?
zacks.com - Aug 14, 2026
Edwards Lifesciences pairs accelerating structural heart growth and stronger leverage with a premium valuation that leaves less room for execution set
Edwards Climbs 14% in 3 Months as Growth Strength Tests Valuation
zacks.com - Aug 13, 2026
Edwards' 14% three-month rally reflects broad structural-heart growth, but its premium valuation raises the bar for execution.
EW DCF Analysis: Intrinsic Value $53 vs Price $90
gurufocus.com - Aug 5, 2026
On August 05, 2026, we delve into the DCF analysis for Edwards Lifesciences Corp (EW), a company that has shown mixed price performance recently.
Edwards Lifesciences Corporation $EW Stock Holdings Lessened by Glenmede Trust Co. NA
defenseworld.net - Aug 3, 2026
Glenmede Trust Co. NA trimmed its stake in shares of Edwards Lifesciences Corporation (NYSE: EW) by 4.
Is the Options Market Predicting a Spike in Edwards Lifesciences Stock?
zacks.com - Jul 30, 2026
Investors need to pay close attention to EW stock based on the movements in the options market lately.
How News Affects EW Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track EW's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked EW news questions
- What is the latest EW news headline?
- The most recent EW headline (Aug 14, 2026) is "Is EW Stock Worth Buying as Growth Clashes With a Premium Valuation?". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the EW news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What EW news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual EW options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.